Administering a cholesterol-lowering drug prior to heart bypass surgery or surgical repair of a faulty heart valve may reduce the occurrence of atrial fibrillation, a common heart rhythm disturbance triggered by these surgeries. The research was published in “Circulation: Journal of the American Heart Association.”

Zargis Medical Corp., a spin-off from Siemens Corporate Research and a majority-owned subsidiary of Speedus Corp., has ...

IMV ServiceTrak ranked GE Healthcare No. 1 for CT and MR Service in a comparison against five other manufacturers of the ...

Johnson & Johnson has filed a $5.5 billion lawsuit against Guidant Corp. in U.S. District Court in New York, claiming that Guidant leaked confidential information to Abbott Laboratories to secure a crucial component of the deal with Boston Scientific, reports Modernhealthcare.com.

Drugs traditionally used for the treatment of gastric ulcers could have therapeutic potential in chronic heart failure, according to new research coming out of Japan. One outcome showed that famotidine appears to reduce left ventricular end-diastolic (LVD-d) and end-systolic (LVD) lengths and reduce BNP (B-type natriuretic peptide) levels.

Siemens completed its acquisition of Diagnostic Products Corp. (DPC) in late July, marking a significant milestone for Siemens as it enters the in-vitro diagnostics (IVD) market. Together with DPC, Siemens Medical Solutions says it will become the first full service diagnostics company.

New SPECT/CT, cardiovascular IT and PET/CT technologies were on display by Philips Medical Systems at the American Society of Nuclear Cardiology (ASNC) annual meeting in Montreal.